Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says AnalystBenzinga • 08/15/25
Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave?Zacks Investment Research • 08/15/25
Robbins LLP Urges NVO Stockholders with Large Losses to Contact the Firm for Information about Leading the Class Action Against Novo Nordisk A/SGlobeNewsWire • 08/14/25
Investors in Novo Nordisk A/S Should Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights – NVOGlobeNewsWire • 08/14/25
NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming DeadlinePRNewsWire • 08/14/25
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVOGlobeNewsWire • 08/13/25
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines – NVOGlobeNewsWire • 08/13/25
ATTENTION NYSE: NVO INVESTORS: Contact Berger Montague About a Novo Nordisk A/S Class Action LawsuitPRNewsWire • 08/12/25
Novo Nordisk A/S Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before September 30, 2025 to Discuss Your Rights – NVOGlobeNewsWire • 08/11/25